Chemical modification of membrane proteins in relation to inhibition of anion exchange in human red blood cells.
Mono-, di-, and trisulfonic acids, including 4,4'-diacetamido stilbene-2,2'-disulfonic acid (DAS) and 2-(4'-amino phenyl)-6-methylbenzene thiazol-3',7-disulfonic acid (APMB) produce a reversible inhibition of sulfate equilibrium exchange in human red cells. A study of the sidedness of the action of a number of these sulfonic acids in red cell ghosts revealed that some, like DAS, inhibit only at the outer membrane surface while others, like APMB, inhibit at either surface. This finding suggests that at least two different types of membrane sites are involved in the control of anion permeability. The nature of the anion permeability controlling sites in the outer cell surface was investigated by studying the effects of DAS on the inhibition by dinitrofluorobenzene (DNFB) of anion equilibrium exchange and on the binding of DNFB to the proteins of the red blood cell membrane. After exposure to DNFB in the presence of DAS for a certain period of time, there was a reduction of both the inhibitory effect of DNFB on sulfate exchange and the binding of DNFB to the protein in band 3 of SDS polyacrylamide gel electropherograms (nomenclature of Steck, J. Cell. Biol., 62: 1, '74). Since binding to other membrane proteins was not affected, this observation supports the assumption that the protein in band 3 plays some role in anion transport. In accordance with the absence of an inhibitory effect at the inner membrane surface, internal DAS does not affect DNFB binding to the protein in band 3. DAS protected the anion exchange system not only against inhibition by DNFB but also by m-isothiocyanato benzene sulfonic acid. In contrast to DAS, the equally inhibitory phlorizin does not reduce the rate of dinitrophenylation of the protein in band 3. This suggests that either not all inhibitors of anion exchange exert their action by a combination with sites on the protein in band 3 or that in spite of the described evidence this protein is not involved in the control of anion movements.
D000880:Anthraquinones / Q000494:pharmacology; D001665:Binding Sites / Q000187:drug effects; D001798:Blood Proteins / Q000378:metabolism*; D002462:Cell Membrane / Q000378:metabolism; D002463:Cell Membrane Permeability / Q000187:drug effects*; D004396:Coloring Agents / Q000494:pharmacology; D004139:Dinitrofluorobenzene / Q000378:metabolism; D004912:Erythrocytes / Q000378:metabolism*; D006461:Hemolysis; D006801:Humans; D009282:Naphthalenesulfonates / Q000494:pharmacology; D010695:Phlorhizin / Q000494:pharmacology; D013267:Stilbenes / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013431:Sulfates / Q000378:metabolism*; D013451:Sulfonic Acids / Q000494:pharmacology*; D013844:Thiazoles / Q000494:pharmacology
D000880:Anthraquinones; D001798:Blood Proteins; D004396:Coloring Agents; D009282:Naphthalenesulfonates; D013267:Stilbenes; D013431:Sulfates; D013451:Sulfonic Acids; D013844:Thiazoles; D010695:Phlorhizin; D004139:Dinitrofluorobenzene